Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening

Area of Science:

• Biomedical Engineering
• Toxicology
• Drug Development

Background:

• Improved in vitro models are essential for predicting drug efficacy, interactions, and drug-induced kidney injury (DIKI).
• Organ-on-a-chip technology, specifically kidney-on-a-chip systems, can replicate the human kidney's microenvironment and physiological functions.
• These systems are crucial for advancing drug development and safety assessment.

Purpose of the Study:

• To review the application of microfluidic culturing techniques in kidney-on-a-chip models.
• To highlight the potential of these models for detecting biomarkers predicting drug interactions and DIKI.
• To discuss challenges in high-throughput screening and in vitro to in vivo extrapolation (IVIVE).

Main Methods:

• Focus on state-of-the-art microfluidic culturing techniques for kidney proximal tubules.
• Application of kidney-on-a-chip systems to mimic human kidney properties.
• Review of methods for biomarker detection and high-throughput screening.

Main Results:

• Kidney-on-a-chip models show promise in mimicking human kidney structure and function.
• Microfluidic techniques enable the culturing of kidney proximal tubules for DIKI and drug interaction studies.
• Biomarker detection in these systems can aid in predicting adverse drug reactions.

Conclusions:

• Kidney-on-a-chip technology represents a significant advancement for in vitro drug testing.
• Microfluidic-based kidney models are valuable tools for identifying potential drug-induced kidney injury.
• Overcoming IVIVE challenges is key for the successful implementation of these models in drug development.